275
Participants
Start Date
April 9, 2024
Primary Completion Date
May 31, 2026
Study Completion Date
November 30, 2026
Infliximab
Weekly administration of subcutaneous infliximab.
Infliximab
Bi-weekly administration of subcutaneous infliximab.
Infliximab
Optimized dosing schedule of intravenous infliximab.
RECRUITING
AZ Maria Middelares, Ghent
RECRUITING
AZ Oostende, Ostend
RECRUITING
Universitair ziekenhuis Antwerpen, Antwerp
RECRUITING
Imeldaziekenhuis, Bonheiden
NOT_YET_RECRUITING
AZ Sint-Jan Brugge, Bruges
RECRUITING
Erasme, Brussels
RECRUITING
Ziekenhuis Oost-Limburg, Genk
RECRUITING
AZ Sint-Lucas Gent, Ghent
RECRUITING
Universitair ziekenhuis Gent, Ghent
RECRUITING
Universitair ziekenhuis Leuven, Leuven
RECRUITING
Heilig Hart ziekenhuis Lier, Lier
RECRUITING
CHU Liège - Sart Tilman, Liège
RECRUITING
VITAZ, Sint-Niklaas
RECRUITING
AZ Vesalius, Tongeren
RECRUITING
CHwapi, Tournai
Collaborators (1)
Celltrion
INDUSTRY
Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW
OTHER